CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: Anti-inflammatory Effects of Colchicine in PCI [Phase 4]
Summary
Phase 4 trial reporting anti-inflammatory effects of colchicine in patients with coronary artery disease has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-09-09